Podcasts about mounjaro

Jim Cramer and David Faber explored what to make of earnings from three of the Magnificent 7 mega-caps: Meta shares tumbled and Microsoft's stock fell as AI spending increases overshadowed quarterly beats — while shares of Google parent Alphabet surged on better-than-expected results, fueled by strength in the cloud. Starbucks CEO Brian Niccol joined the program to discuss his company's results and turnaround plan. Eli Lilly CEO David Ricks spoke to Jim and David about his company's earnings and what's next for its Mounjaro weight loss drug. Also in focus: The meeting between Presidents Trump and Xi, Novo Nordisk-Pfizer bidding war, Chipotle plunges, Comcast's earnings message.Disclosure: Comcast is the parent company of NBCUniversal, which owns CNBC.Versant would become the new parent company of CNBC upon Comcast's planned spinoff of Versant.Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

For the first time in a while, obesity numbers are dropping in the U.S.  Some believe it is due to the use of popular GLP-1s such as Mounjaro and Ozempic, but while those drugs may be making people thinner, diabetes rates are on the rise. So what gives? Greg and Holly discuss.

A gain in same-store sales wasn't enough to reel investors back into Starbucks (SBUX). Diane King Hall says a lack of outlook had many investors scratching their heads. Eli Lilly (LLY) rallied after showing strength in its Mounjaro and Zepbound weight-loss drugs. Estée Lauder (EL) posted a profit that Diane King Hall calls a "sigh of relief" for investors.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

In this episode, we take a closer look at tirzepatide, a type 2 diabetes medication also used to help with weight loss. Postmenopause weight gain can be a normal part of aging, and there are some questions about whether medications like tirzepatide could be useful and safe for postmenopausal women. Host Aaron Lohr talks with Maria Daniela Hurtado Andrade, MD, PhD, assistant professor of medicine at Mayo Clinic Florida, and Regina Castaneda, MD, a research fellow at Mayo Clinic College of Medicine & Science. They presented an abstract at ENDO 2025 titled, “One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women With and Without Hormone Therapy.” Show notes are available at https://www.endocrine.org/podcast/enp105 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

In the past week, Ozempic and its role in weight loss have remained at the forefront of health news as public discussion deepens about its efficacy, risks, and the pronounced cultural shift these medications have sparked. Ozempic, known generically as semaglutide and originally developed as a diabetes treatment, is a GLP-1 receptor agonist that works by slowing gastric emptying and suppressing appetite, making users feel full longer and reducing overall food intake. This mechanism has made it exceptionally popular for weight loss, particularly as social media, celebrity testimonials, and off-label prescribing converged to push demand higher than ever before. Market analysts note that by late 2025, the majority of new Ozempic prescriptions are for weight management rather than diabetes, marking a significant departure from its intended clinical use and raising concerns about access for patients with diabetes who genuinely need the drug.The transformation of Ozempic from a type two diabetes solution to a cultural touchstone for cosmetic weight loss is partly credited to the attention from high-profile figures such as Oprah Winfrey. This week, Oprah appeared at the American Ballet Theatre Fall Gala in New York City, her appearance turning heads and fueling conversation due to her notably slimmed-down figure. Reports from Hello Magazine describe Oprah's confidence on the red carpet as she showcased a dramatic weight loss of more than fifty pounds, achieved through a combination of lifestyle modifications and, crucially, the assistance of a GLP-1 medication. At age seventy-one, Oprah has spoken openly this week about the lifelong struggle with her weight and the social stigma that accompanied it. She told People Magazine that after decades of blame and shame, both from external commentators and herself, the availability of medically approved weight loss medications feels to her like both relief and redemption. She described how the weight loss journey for her began in earnest following knee surgery in 2021, when she started an active regimen of hiking and physical fitness, complemented eventually by her doctor's prescription for semaglutide.Oprah acknowledged grappling with the stigma tied to weight loss medications, initially resisting the idea out of concern it may appear she was taking an easy way out. However, recent interviews reveal she has set aside any feelings of shame, now describing the medication as a legitimate tool—one that enabled her to shed long-standing weight and maintain her health, not just for cosmetic reasons but as a genuine medical necessity. Though some have criticized the trend of using medications such as Ozempic, Wegovy, and Mounjaro for cosmetic weight management, Oprah's insights over the week have reframed the conversation for many listeners. She emphasized that the ability to access medication for weight issues in her lifetime is not something to hide but a breakthrough for many who have suffered physically and emotionally from long-term obesity and its attendant health risks.The clinical conversation around Ozempic has also intensified this week. Drug safety concerns, including the risk of gastrointestinal complications such as pancreatitis and gastroparesis, have been spotlighted by healthcare outlets and legal analysts. Regulatory agencies continue to grapple with the surge in off-label use among populations that may not fully meet the criteria for medical obesity, often motivated by the relentless demands of modern aesthetics rather than underlying health needs. Medical professionals report increasing pressure from patients desperate to access these drugs after seeing dramatic transformations online, which has complicated the careful balancing act between ensuring proper care and responding to unprecedented demand.Critically, the public discourse, amplified by Oprah's willingness to openly discuss her experience, is moving the conversation from that of quick fixes and shame to one of nuanced understanding. The stories told this week highlight not only the potential of new medications to change lives, but also the importance of honest dialogue about the physical and emotional realities of weight loss. Social platforms remain abuzz, but the conversation is shifting toward understanding the full spectrum of medical, ethical, and personal implications.Thanks for listening, please subscribe, and remember—this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Come back next week for more.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Zayıflama iğneleri gerçekten çözüm mü, yoksa yeni bir diyet kültürü formu mu?Bu bölümde, son yılların en popüler konularından biri olan GLP-1 iğnelerini konuşuyoruz. Ozempic, Wegovy, Mounjaro gibi isimlerle karşımıza çıkan bu ilaçlar aslında nereden çıktı, ilk başta hangi hastalıklar için geliştirildi ve nasıl oldu da “zayıflama iğnesi”ne dönüştü?Bilimsel ama sade bir dille, tokluk hissinin beyinde nasıl oluştuğunu, GLP-1 hormonunun vücuttaki rolünü, ve bu ilaçların davranışsal etkilerini ele alıyoruz.Ayrıca bir yeme bozukluğu koçu olarak bu tür müdahalelerin, özellikle geçmişinde diyet kültürüyle mücadele etmiş kişilerde hangi duygusal tetiklemeleri yaratabileceğinden de bahsediyorum.

In this episode, PAIN Founder Flindt Andersen and Jason Lachance explore groundbreaking new research on medications like Ozempic, Mounjaro, and other GLP-1 receptor agonists — originally developed for Type 2 diabetes and weight loss — that may also play a significant role in addiction treatment.Early studies suggest these medications could help reduce cravings and relapse rates. In fact, researchers found that People with alcohol use disorder who were prescribed Ozempic or similar drugs had a 50% lower rate of binge drinking. Individuals with opioid use disorder taking these medications had a 40% lower rate of opioid overdose.Flindt and Jason break down what these findings could mean for the future of recovery, and how science continues to expand our understanding of addiction and healing.

In part 2 of this GLP-1 series, Ted shares two real-life case studies that reveal when weight loss drugs like Ozempic, Wegovy, and Mounjaro deliver results—and when they don't. Discover the surprising lessons that make the difference. If you missed part 1, go back to hear Ted break down the dos and don'ts of these drugs, how they work, the results people are seeing, and the lifestyle shifts that ensure lasting success. Listen now!  Click here for part 1:   

Millions of adults take popular drugs like Ozempic, Wegovy, and Mounjaro to treat chronic conditions and/or lose weight. The GLP-1 medications have made headlines for their effectiveness, and new studies have shown that some of them can also curb alcohol and drug consumption and lower the risk of a heart attack. But not everyone has equal access to the medications. While some patients are able to obtain them through their health care providers, others have turned to online platforms that don't require prescriptions. In many cases, they can also be cost prohibitive: Ozempic, for example, can cost up to $1,000 per month without insurance. This hour, we explore the latest with these medications: what they treat, how they work, and who should be able to access them. Our guests: Zachary Burns, D.O., assistant professor of family medicine at the University of Rochester Medical Center and associate director of Moving Medicine Forward  Erica Davis, patient who uses weight loss medication, theater professional, educator, and mother Molly Ranney, MS, RD, CDN, CSOWM, lead dietitian for the Bariatric Center at Highland Hospital Kaci Schiavone, M.D., assistant professor in the Department of Surgery, Bariatric/GI at the University of Rochester Medical Center ---Connections is supported by listeners like you. Head to our donation page to become a WXXI member today, support the show, and help us close the gap created by the rescission of federal funding.---Connections airs every weekday from noon-2 p.m. Join the conversation with questions or comments by phone at 1-844-295-TALK (8255) or 585-263-9994, email, Facebook or Twitter. Connections is also livestreamed on the WXXI News YouTube channel each day. You can watch live or access previous episodes here.---Do you have a story that needs to be shared? Pitch your story to Connections.

When Serena Williams shared that she lost over 30 pounds in eight months using a GLP-1 weight-loss medication, the internet lost its mind. Accusations of "cheating," debates about fairness, and endless opinions followed — but Dr. Joe says it's time we stop judging people for using proven medical tools. In this episode, Dr. Joe breaks down: ✅ Why even elite athletes struggle with weight loss ✅ The science behind GLP-1s (Ozempic, Mounjaro, etc.) ✅ Why "discipline" isn't the only answer ✅ How obesity is not a moral failure — it's a medical condition ✅ What this backlash really says about our culture and stigma If you've ever judged someone for taking a weight-loss medication — or felt judged yourself — this is a must-watch.

Check out my playlist!https://open.spotify.com/playlist/7J0ac0SgxZCg6aCMZgFHPp?si=Uql5G6VDSsCXl0urVAuGUAHowdy Hello and welcome to "Phat Love Talk"! I'm your host, Phat Love, and I'll be taking you on a journey through news and media I find interesting! TV Shows and Movies you should be watching, Sports conversations, Books I enjoyed reading and even some personal topics like my journey with weight loss on Mounjaro, Mental Health and living with Anxiety, Depression and ADHD. Be sure to check out my brother podcast, "AlphaPhenomenon Gaming Podcast", for all future gaming episodes. This ones for me, care to take a seat and listen?

Send us a textThis week, I'm joined by Dr. Betsy Greenleaf, board-certified female urogynecologist and women's health expert. We talk about menopause, perimenopause, weight gain, the new weight loss drugs, HRT (hormone replacement therapy), pelvic health, and vaginal wellness. Betsy explains how to stay strong, confident, and comfortable in midlife, the difference between natural and synthetic hormones, and how to make HRT work for you. We also cover weight-loss drugs like Ozempic, Mounjaro, and Wegovy, why they're not a long-term solution, and the importance of muscle, stress reduction, and nutrition for midlife wellness.Plus, Betsy shares her top tips for pelvic health, including Kegels, topical oestrogen, red-light therapy, probiotics, and boric acid resets, and her golden rule for midlife self-care: give yourself grace.It's an honest, empowering and incredibly informative conversation we all need to hear.Linkshttps://buymeacoffee.com/amandaryderBetsy's Pelvic Floor Store that she mentionedJust by clicking on the link you will receive 10% off Betsy's productsThe Pelvic Floor Store:  https://pelvicfloorstore.com/discount/BETSYGREENLEAFSTORE  https://pauseinstitute.comhttps://www.instagram.com/drbetsygreenleafAmanda Ryder Registered Nutritional Therapist ~ Author of Feel good for Menopause @amandarydernutritionhello@amandaryder.co.ukwww.amandaryder.co.uk

✨ The GLP-1 Circle Membership is opening the doors soon, available for all GLP-1 users, it's your hub for dietitian/personal trainer support on your GLP-1 journey for only $99/month. Get first dibs on membership spots here: Join the waitlist

Weight-loss drugs like Ozempic®, Wegovy®, and Mounjaro™  or GLP-1 can reset your appetite—but only you can rewire your brain. In this episode, I'm showing you how to use your quiet-appetite season on Ozempic as a bridge, not a crutch. You'll learn how to shift from the Dieter's Mindset to the Stop Dieting Forever Mindset and build habits that actually stick while your food noise is quiet. ✨ What You'll Learn in This Episode: Why Ozempic can change your biology—but not your beliefs How to reprogram habits while your appetite is quiet The difference between the Dieter's Mindset and the Stop Dieting Forever Mindset How to apply the Four ForeverWell Essentials  A guilt-free way to enjoy treats—with grown-woman boundaries How to use self-coaching to manage stress and cravings The TikTok story that shows what happens when you skip the mindset work ====================== FEATURED ON THE SHOW / RESOURCES

According to a KFF poll, about one in eight, or 12%, of adults in the United States have used a GLP-1 medicine like Ozempic, Trulicity, Victoza, Mounjaro, Wegovy, or Zepbound. These drugs were originally developed to treat diabetes, but quickly started being prescribed for weight loss and other uses. While they seem like wonder drugs, GLP-1 medicines do cause side effects and have risks. Nausea, vomiting, diarrhea, and constipation are common side effects. The drugs also can cause dizziness, headaches, and elevated heartbeat.  Dr. Neil Iyengar is a breast medical oncologist who studies how diet and exercise can improve quality of life for people with breast cancer. He's also prescribed GLP-1 medicines for the people he cares for. Listen to the episode to hear Dr. Iyengar explain: how GLP-1 medicines work the risks these drugs may pose for people receiving chemotherapy, immunotherapy, or a CDK4/6 inhibitor why he works closely with a weight loss specialist or endocrinologist when prescribing these medicines why the medicines work best when a person also makes lifestyle changes

Are Ozempic, Wegovy, and Mounjaro really the miracle solution for weight loss? In part 1 of this 2 part series, Ted breaks down how GLP-1 drugs work, the results people are seeing and the potential downsides no one talks about. Plus, the lifestyle shifts that ensure lasting success. Listen now! 

Siquoyia Blue interviews Michelle about starting Mounjaro after a borderline diabetic A1C, the side effects she experienced (headaches, constipation, fatigue), and how she managed them. Michelle shares results—about 15 pounds lost in six weeks—advice for people who can’t exercise, thoughts on safety comparing doctor‑prescribed drugs vs. online GLP‑1s, and the importance of mental health and self‑confidence when using weight‑loss medications. Subscribe to Blu Alchemist Podcast Substack Newsletter: https://siquoyiablue.substack.com/ Podcast ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website: https://www.blualchemistpodcast.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Siquoyia Blue Website: https://siquoyiablue.komi.io⁠⁠⁠⁠ YouTube: @blualchemistpodcast Buy Dating Assassins Card Game: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.datingassassins.com ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want to either be a guest on or find guests for your podcast, please sign up here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.joinpodmatch.com/siquoyia⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Donate via Cashapp: @KingSiquoyia or Venmo: @KingShay Thanks for listening! Subscribe, Share and Follow us!

Can medications like Ozempic and Mounjaro actually do more than help you lose weight? This minisode features highlights from our full conversation, which premiered October 7th, 2025. Watch the full episode here → https://youtu.be/AcVIiy201H4?si=nlaFL3JnoZHxQVFh Dr. Rocio Salas-Whalen and I explore the difference between GLP-1, GIP, and triple-agonist drugs — and what's next in obesity medicine, how estrogen changes after 40 drive midsection weight gain and inflammation, why GLP-1s reduce cancer and Alzheimer's risk through anti-inflammatory and neuroprotective effects and how obesity and insulin resistance impact fertility and PCOS — and how GLP-1s can help.If you've ever wondered whether GLP-1s are just “weight loss shots” or a real step forward in metabolic and brain health — this “minisode” is a must-listen. *** Follow Dr. Salas-Whalen: Instagram: @drsalaswhalen TikTok: @drsalaswhalen @strengthmd @thedryrevolution *** I'm Louisa Nicola — clinical neuroscientist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_ Topics discussed: 00:00 – Intro 00:04  – The Probiotic GLP-1 Myth 00:19 – The “iPhone Evolution” of GLP-1 Drugs 00:52 – GLP-1 vs GIP vs Triple Agonists Explained 01:24 – Phase 3 Results & Massive Weight Loss Outcomes 01:38 – The Role of Glucagon in Weight Loss 01:56 – Menopause, Estrogen & Midlife Weight Gain0 3:06 – The “Fat Shift” After 40 04:01 – Can You Combine HRT and GLP-1s? 06:17 – “Willpower” vs Biology in Obesity 07:49 – The Genetic and Hereditary Roots of Obesity 08:57 – Breaking the Transgenerational Cycle 09:30 – Thyroid Cancer Myths and GLP-1 Safety 10:49 – GLP-1s and Breast Cancer Prevention 12:06 – Inflammation as the Root of Disease 12:28 – Neuroprotection and Alzheimer's Prevention 13:17 – GLP-1s, PCOS & Fertility Benefits 13:53 – The Positive Ripple Effect on Mental Health 14:21 – GLP-1s Reduce Alzheimer's Risk by 33% 14:58 – The Future of Metabolic Health Learn more about your ad choices. Visit megaphone.fm/adchoices

Girl, I am so over these creepy AI “fitness” ads. Filters are bad enough but now we have actual robots preaching toxic diet culture BS! It's wild how far we've come from Photoshop and filters — now we're literally being sold body image standards that don't even exist.In this episode, I'm venting (because seriously, what is happening?!) but also unpacking what this means for those of us healing our relationship with our bodies. Because if you're already struggling to feel good in your skin, seeing these fake “fitfluencers” can seriously mess with your head.We'll talk about: 

Drugs like Ozempic and Mounjaro were first developed to treat diabetes. They turned out to be so effective at helping people lose weight that new versions were approved for weight loss. And now, their use has skyrocketed. One in every eight American adults has taken what are known as GLP-1 drugs. They not only lead to health benefits associated with weight loss, like lower risk of heart attack and stroke, they also seem to tame addictive cravings and boost sleep. Coming up at 9 a.m. on Wednesday, MPR News guest host Catharine Richert talks with a doctor and a dietitian about the exploding popularity of GLP-1 drugs, side effects and how to use them responsibly.

Are you on a GLP-1 medication like Ozempic or Mounjaro — and wondering if there's a natural way to come off it safely? In this powerful solo episode, Shana breaks down what causes GLP-1 to become depleted, how to rebuild your body's natural production, and the exact steps she recommends for weaning off meds. You'll also hear a detailed walkthrough of her proven weaning protocol (with screen recording!), plus the lifestyle strategies and tools that support long-term metabolic healing. If you're looking for lasting freedom from weight struggles, blood sugar crashes, and medication dependency — this episode is for you.

Could GLP-1s like Ozempic and Mounjaro be making you feel less motivated? Registered Dietitians Kait Richardson and Megan Ware explore how weight loss medications impact the brain's reward (dopamine) system for better or for worse.Get your own personalized nutrition plan!Work 1:1 with Kait & Megan: ⁠⁠⁠⁠www.orlandodietitian.com⁠⁠⁠⁠Follow us on Instagram: Nutrition Awareness: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/nutrition.a..⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Our books:You can order How to Eat Like a Normal Person: A Guide to Overcoming the All-or-Nothing Mindset with Food & Diet ...on ⁠⁠⁠Amazon⁠⁠⁠⁠!And The Optimized Life ... on Amazon⁠⁠⁠ ⁠here⁠⁠⁠⁠!Speaking:Kait is available for virtual and in-person speaking events to inspire your team to stop dieting and eat healthier. Learn more on her website ⁠⁠⁠⁠www.kaitrichardsonrd.com⁠⁠⁠⁠.Disclaimer: Kait and Megan are Registered Dietitians, not licensed therapists or medical doctors. This information is for educational and entertainment purposes only. It is not meant to be a substitute for mental health counseling or medical advice.

In today's episode, I'm diving into everything you need to know about Zepbound (tirzepatide) — the newest obesity medication now available in Canada. I'll explain how this dual GIP/GLP-1 agonist works, how it's different from semaglutide (Ozempic/Wegovy), and who it may be helpful for.We'll talk about expected weight loss results, side effects, cost, and access, as well as one really important topic: how to protect your muscle and bone health while on these medications. Rapid weight loss can come with downsides — and I'll share what you can do to make sure your journey is sustainable and healthy.In this episode, I cover: → How tirzepatide works and what makes it unique → Expected weight loss and blood sugar improvements → Common side effects and safety considerations → Tirzepatide vs. semaglutide — what's the difference? → Cost, access, and insurance coverage in Canada → Why protein and strength training are essential during weight lossAs always, this podcast is for educational purposes only and not a substitute for personalized medical advice. Please talk to your doctor before making any changes to your treatment plan.Come connect with me on Instagram @sashahighmd, and don't forget to subscribe so you never miss a Monday episode! Other episodes: 108. All About Wegovy97. All About Mounjaro53. All About Ozempic145. Which one is better, Ozempic, Wegovy or Mounjaro?

Ozempic remains at the center of American conversations around weight loss, especially as the demand for prescription medications aimed at shedding pounds continues to surge nationwide. This past week, two topics have dominated news coverage. First, the ongoing popularity and the urgent warnings about counterfeit versions of weight loss drugs like Ozempic. Second, the role that Oprah Winfrey's public statements are playing in influencing perceptions about what these medications can—and cannot—actually do.According to ABC News, federal officials are sounding the alarm as more patients turn to online sellers for Ozempic and similar drugs, leading to what Homeland Security calls an “absolutely” unprecedented surge in dangerous counterfeits. Many of these illegal sellers use phrases like “No Rx” to bypass regulations, promising weight loss drugs without prescriptions or safety guarantees. The Food and Drug Administration clarifies that Ozempic, Wegovy, and Mounjaro are tightly regulated, manufactured under strict scrutiny, and are only legal with a prescription. In contrast, unofficial versions dubbed “Fauxzempic” can be counterfeit and potentially life-threatening. Recent coverage stresses that anyone seeking true Ozempic should rely solely on licensed medical professionals and FDA-approved pharmacies to avoid potentially severe health risks.This swell in demand for ozempic and its lookalikes comes as people report dramatic results. Yet, the landscape is muddied not just by fake medicines but also by fraudulent endorsements using celebrity imagery and artificial intelligence. WCPO reports this week on how scammers are exploiting advanced technology to create deepfake videos of Oprah Winfrey allegedly promoting various supplements that claim to mimic Ozempic's effects. These deceptive ads have tricked some consumers into spending hundreds of dollars on unknown substances shipped with no instructions and no scientific backing. Both the Better Business Bureau and independent investigative reports confirm Oprah Winfrey has repeatedly stated she does not endorse any over-the-counter supplement or nonprescription product for weight loss. Deepfake technology now allows scammers to fabricate realistic celebrity recommendations, making it increasingly difficult for ordinary people to separate truth from fiction.Oprah's real stance on Ozempic and weight loss has been thoughtfully discussed in recent interviews and podcasts. On a Yale University obesity medicine episode of The Oprah Podcast, Oprah explained she had long believed thinness was purely a matter of willpower. That changed when she used a prescription GLP-1 medication herself. Oprah described how she finally understood that for many, including herself, the battle with weight is between biology and behavior. She spoke of “food noise”—the constant thoughts and cravings that affect those struggling with obesity—and admitted that, even with medication, this noise never truly disappears. She emphasized medications like Ozempic are not magic bullets, pointing out that any sustainable weight loss for her requires exercise, vigilance, and ongoing lifestyle changes. In her own words published by People and reiterated in current reports, Oprah acknowledged relief and “redemption” in having medical tools to manage her health after decades of blame and shame but firmly denies these medications should be seen as effortless solutions.Simultaneously, current research is highlighting new and unusual side effects associated with using Ozempic and similar drugs, especially in medical imaging. The Independent this week shared findings that patients who use these medications and then undergo PET scans might experience “hot spots” during imaging, potentially complicating diagnostic procedures for certain conditions. This development underscores the importance of informing healthcare providers about any recent prescriptions for GLP-1 drugs, so they can interpret medical images accurately and avoid misdiagnosis.As the popularity of Ozempic and similar drugs reaches new heights, federal warnings about dangerous counterfeits, widespread misinformation fueled by deepfakes and fake endorsements, and evolving understanding of side effects form the core of this week's ongoing story. All experts stress the importance of relying on your physician and FDA-approved pharmacies for health decisions, and not succumbing to slick videos or promises from online sellers. Oprah Winfrey's honest reflections have helped reframe the public conversation, reminding listeners that healthy weight loss is both a medical science and a personal journey, not a simple secret or shortcut.Thanks for listening, please subscribe, and remember—this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Come back next week for more.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

We're going there today.Ozempic, Wegovy, Mounjaro — the weight-loss drugs everyone's talking about.But here's what no one's saying: yes, these meds work… but at what cost?In this episode, Nikkiey Stott breaks down the truth about GLP-1 weight-loss drugs, the science behind how they actually work, and the reality of what happens when you stop taking them. She dives into the research on muscle loss, metabolism slowdown, and why relying on medication alone sets so many women up for the rebound cycle they've spent years trying to escape.This isn't about fear — it's about facts.You'll walk away understanding: • Why muscle is the single most important factor in fat loss after 40 • What studies really show about GLP-1s and metabolism • The right vs. wrong way to use weight-loss meds (if you choose to) • And the exact lifestyle framework that always wins — with or without a prescriptionIf you're tired of chasing shortcuts and ready to finally understand how to create sustainable results, this episode will change the way you see your body, your health, and your power.

Inside the black market of fake and illicit versions of drugs used for weight loss like Ozempic and Mounjaro. Plus, Riverdale's Lili Reinhart explores the dark world of content moderation in new film. And the uproar over A.I. 'actress' Tilly Norwood. Learn more about your ad choices. Visit podcastchoices.com/adchoices

It's Pop Culture Thursday, which means Jared dives into Page Six and lets the riffs fly. He breaks down the “snub or not” moment between Charlize Theron and Johnny Depp at Paris Fashion Week, then pitches the rom-com we all deserve: Lana Del Rey and her alligator wrangler husband taking on haute couture. Jared questions why Travis Kelce gets boyfriend bonus points for spending his birthday at Taylor's movie premiere and contrasts the vibes and fans of Taylor Swift versus Charli XCX amid that “actually romantic” dust-up. He talks about Amy Schumer's very public Mounjaro journey and how the internet bullies celebrities into over-explaining. Finally, he weighs in on the “very real” PDA tour of Sydney Sweeney and Scooter Braun and why people seem weirdly suspicious of her every move!Get $10 off your first month's subscription of Nutrafol & free shipping with promo code FEATHER at https://www.nutrafol.com

In this episode of the Heart to Heart podcast, Dr. Mike Hart sits down with Dr. Ted Naiman, a family medicine physician from Seattle with a passion for diet and exercise. They discuss the importance of family physicians in healthcare, Dr. Naiman's personal fitness transformation focusing on a high-protein, low-carb diet, and the significance of satiety over counting calories. Dr. Naiman shares his views on effective exercise routines, optimal macronutrient ratios, and the advantages of front-loading protein. They also delve into insulin resistance, the use of fasting triglycerides as a marker, and the potential of GLP-1 medications for weight loss and insulin sensitivity. This comprehensive discussion provides actionable insights into improving metabolic health and body composition. Dr. Ted Naiman is a family physician, author, and leading voice in evidence-based nutrition and metabolic health. With over two decades of experience in primary care, Dr. Naiman has dedicated his career to helping people understand the science of body composition, satiety, and sustainable weight management. Learn more at tednaiman.com  and on LinkedIn.   Links: The P:E Diet — by Dr. Ted Naiman Fairlife Milk (ultra-filtered milk)   Show Notes: 00:00 Welcome back to the Hart2Heart Podcast with Dr. Mike Hart 00:30 Dr. Ted Naiman's background 01:30 Transformation journey 02:00 Diet and exercise philosophy 03:00 Calorie counting debate 05:30 Macro ratios and protein focus 09:30 Daily meal timing and strategy 13:27 “Front-load your protein. If you start your day with donuts, you'll eat more all day. If you start with protein, you'll automatically eat less.” 20:30 Sources of protein 25:00 Carbohydrate choices 29:00 Fat sources and supplementation 34:00 Understanding insulin resistance 37:30 Understanding insulin sensitivity and resistance 39:00 Indicators of insulin resistance: triglycerides and HDL 43:30 The role of fasting insulin and glucose 50:30 Training recommendations: cardio vs. weights 52:30 Effective resistance training strategies 59:30 Visceral fat: causes and reduction strategies 01:05:30 The role of GLP-1 in weight management 01:14:30 Conclusion and final thoughts   — The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to  cutting through the noise and uncovering the most effective strategies for optimizing health,  longevity, and peak performance. This podcast dives deep into evidence-based approaches to  hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise  protocols, leveraging sunlight light, and de-prescribing pharmaceuticals—using medications only when absolutely necessary.   Beyond health science, we tackle the intersection of public health and politics, exposing how  Policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being.   Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen).   If you're ready to take control of your health and performance, this is the podcast for you. We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect on social with Dr. Mike Hart: Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart  

Six months after launch, Eli Lilly's Mounjaro is already India's second-biggest pharma brand, ahead of antacid Pan and just behind antibiotic Augmentin. Days later, Eli Lilly announced a $1 billion investment and a new Hyderabad hub.The timing is no accident: India has one of the world's largest obese and diabetic populations, Ozempic's patent expires in 2026, and local pharma giants are gearing up with cheap GLP-1 generics.In this episode of Daybreak, we unpack how this landscape presents both an opportunity and a challenge for Eli Lilly.Daybreak is produced from the newsroom of The Ken, India's first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.

Hoy quiero hablarte de dos medicamentos que se han vuelto cada vez más populares: Mounjaro y Rybelsus. Probablemente has escuchado que ayudan a bajar de peso, que son ‘la nueva revolución', o incluso que reemplazarán a Ozempic… pero, ¿qué hay detrás de todo esto? En este episodio te voy a explicar cómo funcionan, en qué se parecen y en qué se diferencian, y lo más importante: qué papel realmente tienen dentro de un cambio de hábitos saludables. Canal de Youtube Visita nuestra página web:  Hábitos Inteligentes ¡Síguenos en instagram!  Agenda tu cita por WhastApp     

Can obesity, menopause, and even Alzheimer's risk be transformed with one class of medications? Triple board-certified endocrinologist Dr. Rocio Salas-Whalen joins The Neuro Experience to unpack the science behind GLP-1 therapies, sustainable weight loss, and hormone health. One of the earliest physicians to adopt GLP-1 treatments, Dr. Salas-Whalen has redefined how obesity and midlife health are managed—showing why weight gain isn't about “willpower” but biology, inflammation, and longevity. A leader in obesity and hormone medicine, Dr. Salas-Whalen founded StrengthMD and The Dry Revolution, sharing evidence-based wellness insights worldwide. Her upcoming book, Weightless: A Doctor's Guide to GLP-1 Medications, Sustainable Weight Loss, and the Health You Deserve, launches Dec 30, 2025 (U.S./Canada) and early 2026 worldwide. Follow Dr. Salas-Whalen: Instagram: @drsalaswhalen TikTok: @drsalaswhalen @strengthmd @thedryrevolution Subscribe to The Neuro Experience for more conversations at the intersection of brain science and performance. I'm committed to bringing you evidence-based insights that you can apply to your own health journey. *** A huge thank you to my sponsors for supporting this episode. Check them out and enjoy exclusive discounts: Puori Go to https://puori.com/NEURO and use the code NEURO at checkout for 20% off. Wildgrain For a limited time, Wildgrain is offering our listeners $30 off the first box - PLUS free Croissants in every box - when you go to https://Wildgrain.com/NEURO to start your subscription.  OSEA Get 10% off your first order sitewide with code NEURO at https://OSEAMalibu.com. You'll get free samples with every order, and free shipping on orders over $50. Honeylove Save 20% Off Honeylove at https://honeylove.com/NEURO. Brickhouse Nutrition Check out the university study and get 20% off when you use promo code NEURO at https://brickhousenutrition.com. Eko Health Get $50 off, plus a FREE custom chest piece cover ($25 value) when you go to https://ekohealth.com/NEURO  *** I'm Louisa Nicola — clinical neuroscientist — Alzheimer's prevention specialist — founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain — reducing Alzheimer's risk — and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_ Topics discussed: 00:00 – Intro 01:44 – Dr. Rocio's Journey into Endocrinology 02:38 – Discovering the First GLP-1 Drug 03:29 – Early Results & FDA Approval 05:00 – GLP-1 101: What It Is + How It Works 06:28 – Natural vs Synthetic GLP-1s 07:09 – GLP-1s & Alzheimer's Link 08:20 – GLP-1s vs Bariatric Surgery 09:32 – Rewiring Cravings in the Brain 11:24 – Anti-Inflammatory Benefits of GLP-1s 11:24 – Ad 15:19 – Ozempic, Mounjaro & Next-Gen GLP-1s 17:02 – GLP-1s & Women's Hormones 19:26 – Will You Be on GLP-1 Forever? 21:35 – The Myth of Willpower 23:22 – Breaking Generational Obesity Cycles 24:43 – GLP-1 & Thyroid Cancer Myth 25:55 – Ad27:55 – GLP-1s Reduce Cancer Risk 29:12 – Inflammation & GLP-1s 30:00 – GLP-1s & Fertility (PCOS) 31:27 – GLP-1 Meds Cut Dementia Risk by 33% 32:04 – Muscle Loss on GLP-1s? 33:14 – Muscle: Your Body's Anti-Inflammatory Organ 34:01 – How to Eat Enough Protein on GLP-1s 35:19 – Tracking Your Body Composition 36:57 – Build Muscle While Losing Weight 37:25 – GLP-1 Side Effects & How to Avoid Them 38:24 – The GPS Method (GLP-1 + Protein + Strength) 38:24 – Ad 41:15 – Exposing “GLP-1 Gummies” & Celeb Hype 41:34 – Microdosing & Maintenance Explained 45:01 – The Emotional Shift in Patients 46:07 – The Future of GLP-1s 48:04 – Ending Chronic Disease Learn more about your ad choices. Visit megaphone.fm/adchoices

SUPPORT OUR WORK: OTPLinks.com

GLP-1s — Ozempic, Wegovy, Mounjaro — they are everywhere right now. Your group chat's talking about them, they're all over TikTok, and maybe even your doctor's mentioned them. You've probably heard that they help with weight loss or that they ‘quiet food noise' — but what's really going on inside your body when you're on these meds? And more importantly what should we, as women, actually know when it comes to our hormones, metabolism, and long-term health? Because let's be real our bodies are not one-size-fits-all, and wellness isn't just about shrinking down a size. So today, we're getting into the real talk: what GLP-1s do, the benefits, the downsides, and how nutrition still plays a major role — whether you're on them, thinking about them, or just trying to make sense of all the hype. Listen up!  The Flourish Heights Podcast was made for women, by women. To be empowered in health starts with a true connection with your body. Join Valerie Agyeman, Women's Health Dietitian as she breaks through topics surrounding periods, women's nutrition, body awareness, and self-care.  Stay Connected: A research review on GLP-1's: https://pmc.ncbi.nlm.nih.gov/articles/PMC10972401/ Follow us on social media: Instagram: @flourishheights / @valerieagyeman / Women's Health Hub: @flourishvulva Is there a topic you'd like covered on the podcast? Submit it to hello@flourishheights.com Say hello! Email us at hello@flourishheights.com Subscribe to our quarterly newsletters: Flourish Heights Newsletter Visit our website: www.flourishheights.com Want to support this podcast? Leave a rating, write a review and share! Thank you!

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________This isn't medical advice — always talk to your doctor before making any health decisions.Join us for an eye-opening conversation with Dr. Komal Patil-Sisodia, MD, a board-certified endocrinologist and obesity medicine specialist, as we uncover why healthcare access is so broken for patients seeking GLP-1 treatments and women's health support. From insurance denials to systemic inequities, Dr. Patil-Sisodia breaks down where the system fails—and how it could change for the better. We're also joined by Sabina, founder of GLP Winner, who shares her personal journey with obesity and her mission to help others find reliable information and providers for GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound.Community Guest: Sabina | https://www.glpwinner.com/ - Helps compare GLP-1 provider options with transparent pricing, sourcing, and reviews.https://www.tiktok.com/@lawliepophttps://www.instagram.com/lawliepops/https://www.youtube.com/@lawliepophttps://x.com/lawliepopDoctor Guest: Dr Komal Patil-Sisodiahttps://www.instagram.com/drpatilsisodia?igsh=MWZyaHY2Mm1naGVwOA%3D%3D&utm_source=qrhttps://www.tiktok.com/@drpatilsisodia?_t=ZT-8zzn5gQRlvy&_r=1https://www.resetrecharge.com/https://www.eastsidemm.com/_______________________________________________________________Send us Fan Mail! GetClaimable.com/PlusSideZ to appeal your GLP-1 Insurance Denails and use code PlusSideZ to save! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Leave Health Bite a Feedback.Click This Link.Your physical hunger is actually trying to tell you something deeper about your emotional and spiritual needs—and science proves it.Even with powerful appetite-suppressing medications like GLP-1s (Ozempic, Wegovy, Mounjaro), Dr. Adrienne Youdim reveals why emotional hunger still demands to be heard—and why that's actually a good thing for your wellbeing.In this science-backed episode, discover how stress, loneliness, and unmet needs literally trigger the same hunger hormones as fasting, and why appetite suppression doesn't equal emotional regulation.What You'll Learn:The surprising science of how emotional hunger triggers real biological hunger hormones (ghrelin, leptin, GLP-1)Why stress literally makes your hunger hormones spike—it's not just willpower or weaknessHow to identify what you're really hungry for: belonging, respite, validation, or connection"Appetite suppression does not equal emotional regulation. Emotional regulation requires its own attention because emotional eating is a form of reactivity—an automatic, habitual attempt to distract, soothe, or suppress some emotional or spiritual experience." - Dr. Adrienne YoudimCommon Hidden Hungers Explored:Hunger for Belonging: Loneliness and isolation driving you to the pantry instead of toward connectionHunger for Respite: Self-neglect and caretaking burnout manifesting as food cravingsHunger for Validation: High-achiever patterns that once served you now becoming destructiveThe Three-Part Framework for Emotional Hunger:Regulate: Break the reactivity cycle with pause practicesBefore: Immediate reactive response to emotional triggers—reaching for food, scrolling, overworkingAfter: Space between trigger and reaction, calmed nervous system, intentional choiceThe Tools: Deep breathing, body scans, nature walks, guided visualization, five-minute pauses before actingRestore: Build rituals that support emotional regulationBefore: Sporadic self-care, inconsistent coping mechanisms, reliance on reactive behaviorsAfter: Sustainable practices that consistently address emotional needsThe Rituals: Morning journaling, lunch walks, Sunday hikes, creative expression, structured eating and movement routinesReframe: Transform hunger from shame to signalBefore: Viewing emotional hunger as weakness, something to suppress or fixAfter: Understanding hunger as valuable information about unmet needs and misalignment with valuesThe Practice: Ask yourself: "What am I truly hungry for? What deep-seated need is my mind and body trying to attune me to? How can I live more aligned with my true north?"Why GLP-1 Users Have a Unique Opportunity:With the "food noise" quieted, you have the perfect window to build emotional awareness, develop coping skills, and retrain habitual pathways for lasting change beyond medication.Your emotional hunger is a signal—a call to action from your nervous system saying something critical needs a3 Ways that Dr. Adrienne Youdim Can Support You Subscribe to Dr. Adrienne's weekly newsletter https://www.dradrienneyoudim.com/newsletter Connect on Instagram : Follow @dradrienneyoudim for tips and inspiration on well-being and peak performance. Come back next week — Every episode of Health Bite explores the physical, emotional, and spiritual hungers that drive us, and delivers the essential “nutrients” you need to thrive.

GLP-1 medications like semaglutide and tirzepatide — better known as Ozempic, Wegovy, and Mounjaro — are transforming lives through significant weight loss. But along with the health benefits, many patients notice unexpected changes in their appearance: facial hollowing, skin laxity, and body deflation, often referred to as “Ozempic face.”   In this episode of The Aesthetic Doctor Podcast, Dr. Judith Borger explores how GLP-1s affect both the face and body — and what can be done to support our weight loss patients through these changes. Whether you're a a patient curious about safe, effective ways to restore balance and confidence or a provider looking to expand your toolkit of non-surgical treatment, this conversation offers practical strategies, safety insights, and compassionate guidance for navigating the GLP-1 journey.   Dr. Judith Borger Links: www.theaestheticdoctor.com www.instagram.com/doctorborger

Women's health campaigner and menopause activist Carolyn Harris MP tells Lorraine and Trish how going from a size 24 to a size 12 has given her a new lease of life and rebooted her self-esteem. The veteran MP talks through the specifics of getting her prescription, how she injects Mounjaro, the side effects, what she eats now and how she manages her dosage. And she reveals the horrific online abuse she suffered which led her to making this life changing decision. PLUS: Telly watching tips for autumn. Hosted on Acast. See acast.com/privacy for more information.

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have become a cultural phenomenon, transforming appetite regulation and weight loss like nothing before. But with their rise comes a flood of imitators, from flashy “GLP-1 patches” to supplements like Calocurb, all promising the same results without the needles or prescriptions. In this episode, I break down what GLP-1 actually is, how these drugs work, and why they're so effective—not just for weight but also for cardiovascular outcomes. Then I take a closer look at the patches (spoiler: marketing magic, not science) and Calocurb's hops extract, which shows some early promise but lacks long-term data. If you're curious about food noise, appetite regulation, and how to separate science from sales tactics, this one's for you.Highlights:How GLP-1 drugs regulate appetite, cravings, and even food noiseWhy “GLP-1 patches” are all marketing and no scienceWhat Calocurb is, how it works, and the research behind itShort-term vs long-term evidence for appetite control Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwillidenSave 20% on all Nuzest Products WORLDWIDE with the code MIKKI at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comCurranz supplement: MIKKI saves you 25% at www.curranz.co.nz or www.curranz.co.uk off your first order

dohttps://www.instagram.com/p/DPaxhg_CW9B/The GLP-1 diet drugs like semaglutide, Ozempic and Wegovy, and tirzepatide, Mounjaro and Zepbound, help you lose weight could very well kill or at least curb your sex drive. These products also reason is that these medications not only act on your gastrointestinal tract but also on your brain circuitry responsible for appetites, cravings, and reward processing.  They seem to suppress dopamine-driven signals that urge you to continue eating, drinking alcohol, and, yes, having sex. They also enhance while enhancing serotonin signals that curb your desires for intimacy.If you are experiencing this side effect, speak with your medical team about dosage and/or medication adjustments.  No need to suffer or lose a valued relationship.https://www.medscape.com/viewarticle/when-glp-1s-change-patients-libido-what-know-2025a1000pal?form=login#glp1 #libido #intimacy #sex #dopamine #serotonin

Big Pharma has convinced millions that GLP-1 drugs like Ozempic and Mounjaro are the only way to quiet food noise and lose weight. But what if their own studies told a very different story? In this episode, Chalene unpacks shocking findings hidden in plain sight — including why some placebo groups lost weight and what that means for you. She also shares surprising natural options that research shows can help regulate hunger hormones, balance blood sugar, and reduce cravings. If you've ever wondered whether there are safer, more affordable ways to reach your goals without a lifetime prescription, this is an episode you don't want to miss. Watch this episode on YouTube this Sunday!!  https://www.youtube.com/@chalenejohnson/videos  

otplinks.com stallybrand.com (code OTP10) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

I'm back from Disney and my brain feels like… pizza.

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Join us for an eye-opening conversation with Dr. Komal Patil-Sisodia, MD, a board-certified endocrinologist and obesity medicine specialist, as we uncover why healthcare access is so broken for patients seeking GLP-1 treatments and women's health support. From insurance denials to systemic inequities, Dr. Patil-Sisodia breaks down where the system fails—and how it could change for the better. We're also joined by Sabina, founder of GLP Winner, who shares her personal journey with obesity and her mission to help others find reliable information and providers for GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound.Community Guest: Sabina | https://www.glpwinner.com/ - Helps compare GLP-1 provider options with transparent pricing, sourcing, and reviews.https://www.tiktok.com/@lawliepophttps://www.instagram.com/lawliepops/https://www.youtube.com/@lawliepophttps://x.com/lawliepopDoctor Guest: Dr Komal Patil-Sisodiahttps://www.instagram.com/drpatilsisodia?igsh=MWZyaHY2Mm1naGVwOA%3D%3D&utm_source=qrhttps://www.tiktok.com/@drpatilsisodia?_t=ZT-8zzn5gQRlvy&_r=1https://www.resetrecharge.com/https://www.eastsidemm.com/______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 Send us Fan Mail! GetClaimable.com/PlusSideZ to appeal your GLP-1 Insurance Denails and use code PlusSideZ to save! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Leave Health Bite a Feedback.Click This Link.What if I told you that weight loss drugs like Ozempic, Wegovy, and Mounjaro are not just about shedding pounds—but can also reduce the risk of heart attacks, strokes, and even improve sleep apnea?And what if I also told you that while these medications are powerful tools, they're often misunderstood, misused, and surrounded by myths from self-proclaimed “gurus”?In this episode, Dr. Adrienne Youdim, triple board-certified internist and obesity medicine specialist, breaks down everything you need to know about GLP-1 medications. From how they work, to who should actually use them, to why “compounded” versions can be dangerous—you'll finally get the truth about these drugs and how they fit into the bigger picture of health.Don't forget to share this episode with anyone considering these medications or feeling confused by the hype.What You'll Learn From This Episode:How GLP-1 drugs work: Understand why they're more than “diet drugs” and how they affect appetite, gut function, and blood sugar.Side effects explained: Learn about common gut-related issues, rare but serious risks, and how to minimize discomfort.The truth behind “Ozempic face” and “Ozempic butt”: Why weight loss naturally changes body fat distribution—and why it's not unique to these medications.Who should (and shouldn't) take them: Clear guidelines on BMI, comorbidities, and why these drugs aren't for losing just 5–10 vanity pounds.Why compounding is a red flag: Discover why cheaper compounded versions pose major health risks.What's coming next: From oral GLP-1s to triple agents and even potential uses in conditions like Alzheimer's, alcohol use disorder, and fatty liver disease.“These drugs are powerful—not just for weight loss, but for improving overall health. But they must be used with medical oversight, not as quick fixes from unqualified sellers.” — Dr. Adrienne Youdim3 Ways that Dr. Adrienne Youdim Can Support You Subscribe to Dr. Adrienne's weekly newsletter https://www.dradrienneyoudim.com/newsletter Connect on Instagram : Follow @dradrienneyoudim for tips and inspiration on well-being and peak performance. Come back next week — Every episode of Health Bite explores the physical, emotional, and spiritual hungers that drive us, and delivers the essential “nutrients” you need to thrive.

Melt Away Fat! Never Diet Again!! The promises of “magic pills” that will lead to safe, effortless weight loss are everywhere. But while these mythical weight loss products may never exist…the FDA is getting ready to approve something extremely close. The news has been nearly impossible to miss…with a tidal wave of interest in medications that are revolutionizing an innovative approach to weight loss is swiftly evolving. Unlike past diet and weight loss trends, GLP-1 drugs are generating levels of enthusiasm that have rarely been seen. And honestly, there are few examples from history that have generated such impact. What once started as a lesser-known treatment (aiming to control blood glucose levels) of type-2 diabetics has turned Ozempic, Wegovy, Mounjaro, and Zepbound into household names, and brought us to the cusp of a health revolution. Furthermore, the next few days, months, and beyond, are shaping up to be a pivotal time for the GLP-1 landscape…mostly due to the FDA expectantly approving the first orally administered medication for chronic weight management (i.e. oral Wegovy semaglutide) sometime during this fourth quarter of 2025. Though, if this discovery has fueled an unprecedented surge in interest and demand for these current injectable peptides, why then are companies working so hard to make oral tablet forms of weight loss drugs that target the GLP-1 receptor? From a business perspective, there are some obvious advantages…such as oral tablet formulations tend to be cheaper and easier to manufacture and distribute than sterile injector pens. In fact, manufacturing complexity, both in terms of making the peptide active ingredients and producing the final injectors…significantly contributed to both Eli Lilly and Novo Nordisk struggling to supply surging demand for their products following approvals for weight loss indications. And from a patient perspective, oral weight loss pills are attractive for several reasons…most notably enhancing convenience for those who simply prefer pills to injections and making treatment accessible to those who are “extremely needle-phobic.” However, while tablet forms are generally more familiar and accessible to most individuals, the relative success of any oral drugs will likely depend on a combination of price, performance, and side-effect profiles. And although oral Wegovy is expected to be approved first, competition will quickly heat up from a myriad of biopharma companies, including Eli Lilly, Viking Therapeutics, Biomed, and Roche. In fact, Eli Lilly is expected to submit its application soon to the FDA for its once daily oral weight loss drug (with potential regulatory approval in 2026). Regardless, the demand for effective weight loss treatments is huge…and there's ample space in the market for a variety of complementary therapies. According to recent Goldman Sachs projections, the U.S. weight loss medication market will essentially triple to over $60 billion by 2030…with oral versions accounting for a quarter of that total market size. While oral weight loss drugs represent (in my opinion) one of the most significant new product cycles across the entire biopharma sector, there's no guarantee they make an immediate disruptive market impact or outcompete existing injectables long-term. And these will be margin accretive for the pharmaceutical industry's newest cash cow…even if this first wave isn't perfect, there will be a next wave of improvements, and then another new wave of improvements after that (if appropriate).

Rosemary's on Mounjaro – or, rather, compounded tirzepatide – and has a lot of conflicted feelings about it. We're talking shrinking celebrities, the rise of GLP-1s and the massive pendulum swing from body positivity to whatever we're seeing now in this frankly confusing episode of Not Without My Sister.Things we mention include:The Guardian's Today in Focus podcast: What happens when you stop weight loss jabs?Em Clarkson and Alex Light's Should I Delete That?: The rise of Reform and GLP-1sThe chefs creating specific menus for Ozempic patientsSupport the podcast by signing up to our Patreon! Catch up on the full back catalogue of exclusive episodes (and ad-free main episodes!) here: patreon.com/notwithoutmysister – you'll get a bonus episode each and every week, ad-free regular episodes AND access to our exclusive close friends feed on Instagram.And if you have questions, email us! notwithoutmysis@gmail.com. While you're at it, leave us a five-star review! We love those. DM us on Instagram @notwithoutmysister. Hosted on Acast. See acast.com/privacy for more information.

#174  - The Shocking Truth About Ozempic and GLP-1s Your Doctor Won't Tell You with Dr. Jeff Crippen What Your Doctor Isn't Telling You About GLP-1s (And What You Need to Know Before You Fill That Prescription) GLP-1 meds like Ozempic, Wegovy, and Mounjaro have been marketed as magic bullets for weight loss—but there's a whole lot more going on beneath the surface. In this episode, I'm joined by Dr. Jeff Crippen, a chiropractor, naturopath, and creator of the Beyond Ozempic course, to break down what these drugs actually do in your body, how to protect your health while using them—and what your doctor probably didn't mention when handing over the prescription. We talk about: What GLP-1s like Ozempic actually do to your digestion, blood sugar, and muscle mass The real reason so many people regain the weight after stopping the meds The shocking links between GLP-1 use and digestive issues, nutrient deficiencies, and even mental health What you can do to preserve muscle and metabolism while on GLP-1s How to come off them safely—and set yourself up to keep the progress for a lifetime The critical (and completely overlooked) role of stress, trauma, and gut health in sustainable weight loss Plus: why the best long-term fat loss strategy still comes down to very basic but powerful choices If you or someone you love is on a GLP-1 or thinking about it, this episode is required listening. We're pulling back the curtain on what's really happening in your body—and giving you the tools to support it with or without medication.

In this eye-opening episode, Dr. Lindsey Elmore exposes the chaos unfolding in the UK as Mounjaro (weight loss/diabetes medication) prices skyrocket 170% overnight—jumping from £92 to £330 per month. Discover how Eli Lilly's "European price matching" triggered panic buying, crashed pharmacy websites, and left patients spending over £1,000 to stockpile medications. Lindsey examines the real-world impact, even in the U.S.: supply shortages, hoarding behaviors, and the unfair advantage given to those who can afford to bulk-buy versus patients with genuine medical needs. A must-listen for understanding how arbitrary pharmaceutical pricing decisions affect real people's access to life-sustaining medications.Main Topic Introduction00:00-00:30: Discussion focuses on Mounjaro (weight loss/diabetes medication) pricing crisis in the UKThe Price Hike00:37-01:13: Massive 170% price increase starting September 1st, 2025Current price: £92/monthNew price: £330/month (up from planned £122/month)01:25-01:41: Eli Lilly justifies increase as "adjusting prices to match the rest of Europe"Pharmacy Response00:37 & 01:41-02:01: UK's largest online pharmacy "Pharmacy2U" freezes prices, then stops sales entirelyPanic Buying Crisis02:09-02:34: Patients stockpiling medications before price hikes02:22: Pharmacies offering 3, 6, or 9-month bundles02:44-02:59: Real examples: patients buying 7-8 pens, spending over £1,000 in panic purchases04:35: Pharmacy websites crashing from demandSupply Chain Impact02:59-03:24: Hoarding strains supply chains and prevents access for patients who truly need the medication03:24-03:44: Medical experts urge against hoarding injectable medications at homeCore Issues Identified03:51-04:12: Access and fairness concerns - distinguishing between medical necessity vs. cosmetic use05:37-05:57: Drug prices change "for no reason at all" with no patient input06:08-06:27: Need to prioritize patients who medically need medications over those who can afford to stockpileSolutions Proposed04:59-05:27: Work with legislators through existing Inflation Reduction Act framework06:27-06:55: Legislative action needed to control "absurd" arbitrary drug pricing, especially for life-sustaining medicationsEpisode Conclusion07:06-07:14: Show closing: encouraging wise health decisionsBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-lindsey-elmore-show--5952903/support.

Iliza is not inviting anyone on her podcast, so please don't get hacked! Also on the menu, a friend breakup because of Mounjaro and fighting with strangers. See omnystudio.com/listener for privacy information.